Durham’s Vast Therapeutics gets Series A financing to fight superbugs Posted by WRAL News | Dec 10, 2018 The investment provides Vast with funding to advance its nitric oxide technology invented in the laboratory of Prof. Mark Schoenfisch, Vast’s president. Read More